81 (72) Bold

Last year’s ranking: 72

Sales: £106.5m (-7.1%)

Despite heavily promoting the benefits of liquitabs as an alternative to cheaper powder formats, Bold still lost £8m in value. Volumes were down 16.9% (partly due to new, larger family packs). This year, it looks set to keep pushing premium following the launch of 3 in 1 pods in January.